The Road to Precision Medicine for Acute Kidney Injury

Bethany C. Birkelo,Jay L. Koyner,Marlies Ostermann,Pavan K. Bhatraju

DOI: https://doi.org/10.1097/ccm.0000000000006328

IF: 8.8

2024-06-15

Critical Care Medicine

Abstract:Acute kidney injury (AKI) is defined as an abrupt decline in kidney function and is a common form of organ dysfunction in critical illness ( 1 , 2 ). AKI is associated with high mortality in the hospital ( 3 , 4 ) and long term ( 5 ), and AKI survivors are at risk of adverse outcomes including incident and progressive chronic kidney disease (CKD) ( 5 ), cardiovascular disease ( 5 , 6 ), and frailty ( 7 ). Unfortunately, little progress has been made in improving outcomes in these patients, with mortality rates remaining fairly stable over the past decade ( 8 ). AKI is not a distinct disease entity but rather a syndrome that encompasses a myriad of underlying pathophysiologies. This heterogeneity is not captured in the current AKI classification system, which is based solely on changes in functional markers of the kidneys, specifically the magnitude of elevations in serum creatinine (SCr) and decreases in urine output (UOP) ( 9 ).

critical care medicine